Learn and discuss how to manage your Distribution activities GDP-compliant.
Exchange opinions and convey possible solutions to problems addressed in case studies.
Benefit from the speakers’ experience in industry, authority and legal advice.
Hintergrund
Quality requirements for medicines do not end after production and packaging. Medicines and APIs are often shipped over long distances and different climate zones and stored in various warehouses. Once the WHO has taken the lead with its guidelines „Good Storage Practices for Pharmaceuticals“ (2003) and „Good Distribution Practices for Pharmaceutical Products“ (2010), more and more compliance with good storage, transportation and distribution practice was emphasised worldwide. Another milestone were the EU-GDP guidelines from 2013 with a lot of intensified demands.
For quite a while it was rather unclear how these guidelines are applicable in the non-EU country Switzerland. Under the Agreement of 21 June 1999 between the Swiss Confederation and the European Community (Mutual Recognition Agreement, MRA), Switzerland obliged to comply with the EU-GMP regulation. However GDP was not covered.
Since 1 July 2015, the EU GDP guidelines do also apply for Switzerland (final implementation on January 1st 2016). This was realised through an adaptation of Annex 2 of Ordinance on Establ ishmentLicences(Arzneimittel-Bewilligungsverordnung - AMBV or Ordonnance sur les autorisations dans le domaine des médicaments - OAMéd).
On 1 January 2019, the revised Therapeutic Products Act (HMG 2) and the majority of the revised implementing ordinances (Therapeutic Products Ordinance Package IV) came into force - with some interesting changes. Various transitional provisions for licenses issued under the old legislation are defined. However, for all new/renewed applications, the new legislation will apply in its entirety.
Zielgruppe
This Live Online Training has been designed for employees, specialists and managers from storage, transportation and distribution as well as their colleagues from quality control, quality assurance and production, which are involved in the various processes of drug logistics.
Technical Requirements
For our webinars, we use Cisco WebEx, one of the leading suppliers of online meetings. At http://www.webex.com/test-meeting.html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in. Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.
09.10 – 10.00 h Legal Bases for the Distribution of Medicinal Products
Legal basis in Switzerland including EU regulations
The Ordinance on Establishment Licences OEL (AMBV, OAMéd)
The revised Therapeutic Products Act (HMG 2): relevant changes
GMP/GDP Interface
Working with contractors
10.00 – 10.20 h Break
10.20 – 11.40 h Tasks and Responsibilities
Requirements and due diligence for the Responsible Person according Art. 9 and 13 of the Ordinance on Establishment Licences
Storage and distribution: current expectations
Cross-border Distribution: Requirements for Import andExport
Requirements for specific products
Qualification of suppliers and recipients
Senior Management
Responsible Person
11.40 – 12.30 h Liability
Principles of liability
Who is liable?
Potential sanctions
Examples from the real life, case law
12.30 – 13.30 h Break
13.30 – 15.30 h Storage and Transport: Practical Aspects a) Warehouse
Requirements
Qualification
Mapping
Hygiene
Documentation
b) Transport
Transport qualification/ validation
Transport at ambient conditions: expectations and control
Deviation Management
Cool and cold chain
Risk Analysis
Training
15.30 – 15.50 h Break
15.50 – 17.15 h Practical Implementation in Switzerland
The GDP Inspection: what do inspectorates expect and how to prepare
Wholesaler vs. Pre-Wholesaler: interfaces and delimitation
Transport at storage conditions: best practices
Case Study: transport validation
17.15 – 17.30 h Final Discussion
Dieses Seminar/Webinar kann nicht gebucht werden. Alternative Termine für dieses Seminar/Webinar und ähnliche Veranstaltungen finden Sie in der Liste aller Seminare.
Für viele Seminare und Webinare gibt es auch Aufzeichnungen, die Sie jederzeit bestellen und anschauen können. Diese Aufzeichnungen finden Sie in der Liste aller Aufzeichnungen.
Oder senden Sie uns Ihre Anfrage einfach über das folgende Kontaktformular.
Teilnehmerstimmen - das sagen andere über unsere Seminare:
„Flüssiger Vortrag, neue Aspekte wurden kommuniziert.“ Rainer Tryankowski, DRK-Blutspendedienst Rheinland-Pfalz und Saarland Webinar GDP Update 2025 März 2025
„Sehr guter Überblick über die aktuellen GDP Themen. Sehr kurzweilig.“ Juliana Dodillet, Pharma Resources GmbH Webinar GDP Update 2025 März 2025
„Sehr ausführliche Erklärung“ Jacqueline Buckel, UNITAX-Pharmalogistik GmbH Webinar GDP Update 2025 März 2025
„Sehr gut: praxisorientiert; Präsentation logisch nachvollziehbar“ Gabriele Unger, Astro-Pharma GmbH Webinar GDP Update 2025 März 2025
„Sehr informativ und umfangreich, aber immer auf den Punkt gebracht“ Jasmine Merz, Peppler GmbH Webinar GDP Update 2025 März 2025